1. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Note from Scottish Intensive Care Society Audit Group There follows a series of figures & tables taken from the Annual Report 2003. Not all tables are suitable for inclusion. To evaluate this method of publication of our results, we would be grateful to receive feedback as to the value of the Annual Report, this presentation and the context in which either have been used by you. Email responses to admin@scottishintensivecare.org.uk. Thank you.

2. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 1. Annual admission rates to Scottish ICUs, 1995 - 2001: a) in cohort of 20 units contributing throughout and b) all participating units.

3. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 2. Trends in bed occupancies (%) in Scottish ICUs, 1999, 2000 & 2001.

4. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 3. Scotland: ICU bed occupancy 1996-2001.

5. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 4. Trends in annual admission rates: 1999-2001.

6. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 5. Trends in Scottish ICU winter bed occupancies: December - March.

7. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 6. Trends in monthly bed occupancies (all units): 1999-2001.

8. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 7. Length of ICU stay, 2001 (Mean & Median).

9. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 8. Length of ICU stay, 2001 (median and inter- quartile range). Scottish median = 2 days, IQR 0.9-5.2.

10. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Table 4. Summary demographic characteristics, 2001.

11. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 9. Proportion of patients ventilated on the first ACP day during 2001.

12. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 10. Proportion of patients ventilated at any time during 2001.

13. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 11. Proportion of patients ventilated at any time in teaching hospital ICUs. (Ninewells: no data 1999-2000).

14. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 12. Proportion of all ventilated patients who are ventilated on the first ACP day in 9 teaching hospitals: 2001.

15. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 13. Proportion of patients in the ICUs who are ventilated on these ACP days.

16. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 14. Proportion of ACP days in which there is ventilatory support: 2001. Mean = 68% of ACP days.

17. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 15. Proportion of ACP days days in which there is ventilatory support alone, with either cardiovasular or renal support, or with both: 2001.

18. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 16. Provision of renal replacement therapy: 2001.

19. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 17. Provision of renal replacement therapy in 2001. Proportion of patients in Scottish ICUs receiving RRT = 8.1%, utilising 8.5% of ACP days.

20. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 18. Proportion of patients receiving inotropes/vasopressors in Scottish ICUs: 2001.

21. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 19. Proportion of patients with PAFC in situ on 1st day of ICU (mean = 6.7%) or at any time during ICU (mean = 10.9%): 2001.

22. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 20. Trend over time of admission sources (N) to Scottish ICUs. Increased numbers in 2001 as all 26 adult, general ICUs participated in 2001, unlike other years.

23. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 21. Trend over time of admission sources (%) to Scottish ICUs. Gives better representation of variation in admissions sources, incorporating all ICUs.

24. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 22. Variation in admissions to ICU from other hospitals.

25. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 23. Illness severity: Median APACHE II scores (inter-quartile range), 2001. Scottish median: 19 (interquartile range 14 & 25).

26. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 24. Scottish overall SMRs (APACHE II model) in 25 units in 2001. Mean: 1.02, 0.995-1.05.

27. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 25. In-hospital mortality of all admissions to Scottish ICUs, 2001.

28. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Table 9. Summary demographic characteristics, 2001.

29. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 26. Scottish SAPS overall SMRs in 25 units, 2001. Mean: 1.31, 1.28-1.35.

30. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Table 10. Variation in illness severity, length of ICU stay and admission APACHE system categories: 1998-2000.

31. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Table 11. Variation in illness severity, length of ICU stay and admission APACHE system categories in all scored patients: 2001.

32. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 27. Scottish SMRs by APACHE system: 2001.

33. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 28. Frequency distribution of prescribing Drotrecogin alfa (activated). N=96. October was an incomplete month.

34. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 29. Use of Drotrecogin alfa (activated) within NHS Boards, N=96 until 31 st July.

35. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 30. Comparison between original and validated APACHE II score for recipients of Drotrecogin alfa (activated).

36. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 31. Annual expenditure on sedatives and NMBAs: 2001/02.

37. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 32. Sedatives and NMBAs as a percentage of ICU drug expenditure.

38. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 33. Ratio of expenditure of NMBAs:Sedatives.

39. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 33. Ratio of expenditure of NMBAs:Sedatives.

40. Scottish Intensive Care Society Audit Group, Annual Report 2003. www.scottishintensivecare.org.uk Figure 34. Sedative costs per day.